ACG 2018 Annual Scientific Meeting

Join GI physicians from around the U.S. and the world for the ACG Annual Scientific Meeting. ACG 2018 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

The ACG 2018 Annual Scientific Meeting is still FREE for ACG members. Attend and earn CME and MOC.

Tuesday, October 9, 2018 | 8:30 AM – 6:25 PM
6:00 am Registration
6:45 am Tuesday Optional Breakfast Sessions - Choose from 8

(You must register and pay separately for breakfast sessions during the registration process.)

Breakfast Session E: Quality and Technique in Colonoscopy: Doing It Better
Moderator: Jason B. Samarasena, MD, FACG

  • Pre-procedural Quality: Getting Them In and Getting Them Clean
    Jason B. Samarasena, MD, FACG
    Discuss interventions to improve colonoscopy preparation quality and patient tolerance, and ways to reduce procedure cancellation through use of navigators, apps, and improved dietary restrictions.
  • Intra-procedural Quality: Technology, Techniques, and Tips to Improve Effectiveness
    Seth A. Gross, MD, FACG
    Describe the current tools and techniques used to improve quality during a colonoscopy, including assistive devices, water techniques, and computer analysis.
  • Post-procedural Quality: How Did We Do and Can We Do Better?
    Irving M. Pike, MD, FACG
    Summarize quality metrics such as ADR, withdrawal, surveillance intervals, adverse event tracking, and other possible interventions to increase quality.

Breakfast Session F: Hot Topics in Liver Disease
Moderator: Renuka Umashanker, MD, FACG

  • Approach to the Patient With Solid and Cystic Liver Lesion
    Renuka Umashanker, MD, FACG
    Outline current guideline recommendations in the evaluation, diagnosis, and management of patients with new liver lesions.
  • Autoimmune Liver Disorders: PBC, PSC, Autoimmune Hepatitis
    David E. Bernstein, MD, FACG
    Discuss current and evolving diagnostic and treatment strategies in the management of autoimmune liver disorders, and the application of new therapeutic modalities in clinical practice.
  • Evaluation of a Patient With Alcoholic Liver Disease
    Vijay H. Shah, MD, FACG
    Summarize current guidelines in the management of patients with alcoholic liver disease, and discuss evidence-based strategies for implementation in clinical practice.

Breakfast Session G: GERD – Weighing the Risks and Benefits
Moderator: Philip O. Katz, MD, MACG

  • GERD Diagnostics – Complementary Not Competitive
    C. Prakash Gyawali, MD, FACG
    Summarize the available techniques and develop a management algorithm for the diagnosis of GERD.
  • Personalized GERD Management
    Rena H. Yadlapati, MD
    Describe the role of medical, endoscopic, or surgical management based on GERD phenotypes.
  • Proton Pump Inhibitors: How to Help Get Your Patients Off of Them
    Philip O. Katz, MD, MACG
    Identify possible strategies to help your patients discontinue the use of PPIs.

Breakfast Session H: Optimizing IBD Management
Moderator: Laura E. Raffals, MD, FACG

  • Treating to Target – What Exactly Should Our Target Be Now?
    Kara M. De Felice, MD
    Define the concept of treat-to-target for patients with IBD.
  • Looking Into the IBD Crystal Ball – Predicting the Course of Disease
    Laura E. Raffals, MD, FACG
    Evaluate available tools for predicting disease course in patients with IBD.
  • Choosing the Right Therapy For Your Newly Diagnosed IBD Patient
    Adam S. Cheifetz, MD, FACG
    Identify how to select the best initial therapy for your patient with IBD.

Breakfast Session I: Endoscopic Management of Perforations and Fistulae
(This session will begin with two didactic lectures followed by a hands-on demonstration in the Hands-on Endoscopy Workshop Center in the Exhibit Hall. The hands-on demonstration is an opportunity for attendees to gain tactile, first-hand experience using a variety of tools and techniques. The hands-on workshop portion of the session does not offer CME.)
Moderator: Laith H. Jamil, MD, FACG

  • Strategies for Chronic Fistulae
    Christopher C. Thompson, MD, MSc, FACG
    Describe endoscopic techniques available for managing chronic fistulae.
  • Medical and Endoscopic Management of Luminal Perforations
    Laith H. Jamil, MD, FACG
    Discuss both medical and endoscopic tools and techniques available for managing luminal perforations.
  • Hands-on Demonstration in the Exhibit Hall

Breakfast Session J: Esophageal Endotherapy
Moderator: Gary W. Falk, MD, MS, FACG

  • Barrett’s Esophagus: Burn, Freeze, or Cut?
    Gary W. Falk, MD, MS, FACG
    Describe techniques of RFA, cryoablation, and EMR/ESD, as well as pros and cons, indications, and outcomes of each technique for treating Barrett’s esophagus.
  • Achalasia: Inject, Dilate, or Cut?
    Walter W. Chan, MD
    Evaluate techniques of botox injection, pneumatic dilation, and POEM, as well as pros and cons, indications, and outcomes of each technique in treating achalasia.
  • Strictures: Dilate, Cut, or Stent?
    Mihir S. Wagh, MD, FACG
    Compare techniques of dilation, endoscopic incisional therapy, and stenting for benign and malignant esophageal strictures, as well as pros and cons, indications, and outcomes of each technique.

Breakfast Session K: Pancreaticobiliary
Moderator: Vivek Kaul, MD, FACG

  • Management of Acute Pancreatitis: The First 48 Hours

    Identify the guidelines and evidence-based early management of patients with acute pancreatitis and how it impacts outcome.
  • ERCP Complications: Prediction, Prevention, and Management
    Vivek Kaul, MD, FACG
    Describe how to best predict, prevent, and manage ERCP complications based on current scientific evidence and guidelines.
  • Management of Complex Common Bile Duct Stones
    Mansour A. Parsi, MD
    Discuss the state-of-the-art approach to management of large and difficult to remove common bile duct stones.

Breakfast Session L: What Is New in Enteropathy?
Moderator: William D. Chey, MD, FACG

  • Diagnosis and Management of Celiac Disease
    Joseph A. Murray, MD, FACG
    Discuss the diagnosis and management of celiac disease and its mimics.
  • Non-celiac Gluten Sensitivity
    William D. Chey, MD, FACG
    Describe the diagnosis and management of patients with non-celiac gluten sensitivity.
  • What Is New in Leaky Gut?
    Julia J. Liu, MD, FACG
    Outline laboratory and endoscopic findings of leaky gut, and recognize the role of leaky gut in the pathogenesis of chronic intestinal disease.
8:30 am Simultaneous Plenary Sessions 2
  • Simultaneous Plenary Session 2A
  • Simultaneous Plenary Session 2B
10:00 am Exhibit Hall Opens
10:15 am Hands-on Endoscopy Workshop Center Opens
10:05 am J. Edward Berk Distinguished Lecture
Fake News and Alternative Facts on Personalized Medicine in IBD
Stephen B. Hanauer, MD, FACG
Introduced by: Irving M. Pike, MD, FACG, ACG President
Discuss best practices in IBD and differentiate the supporting evidence from the current misinformation and misunderstandings that detract from optimal patient care.
10:35 am Break – Visit the Exhibit Hall and Browse Scientific Posters
10:35 am Scientific Poster Session Opens
10:35 am Exhibitor Theater
11:30 am Simultaneous Symposia Session 3

Simultaneous Symposium 3A: Current Challenges and Controversies in the Management of Viral Hepatitis
Moderator: Sonali Paul, MD

  • How to Use Non-invasive Liver Fibrosis Tests in Clinical Practice
    Sonali Paul, MD
    Identify the appropriate use of non-invasive liver fibrosis tests, such as serum fibrosis assays and imaging-based elastography, in clinical practice for patients with viral hepatitis and other chronic liver disorders.
  • Challenges in Hepatitis C Management: DAA Failures, Special Populations, and Controversies
    Mitchell L. Shiffman, MD, FACG
    Describe the evidence addressing current challenges and controversies in HCV therapy, including treatment of DAA failures and special populations, and the association between DAAs and both HCC and HBV reactivation.
  • Challenges in Hepatitis B Management: HBV Reactivation
    James S. Park, MD, FACG
    Discuss evidence-based approaches to challenging issues in hepatitis B management, including the care of chronic HBV in pregnancy, and the evaluation, prevention, and management of HBV reactivation in patients undergoing immunosuppressive drug therapy.

Simultaneous Symposium 3B: Battling Physician Burnout: It Will Take a Village
Moderator: Carol A. Burke, MD, FACG

  • Recognizing Burnout
    Christina M. Surawicz, MD, MACG
    Recognize and identify burnout predictors.
  • What Can Your Institution or Practice Do?
    Joseph C. Anderson, MD, FACG
    Describe what your institution or practice can do to mitigate burnout.
  • The Pathway to Physician Wellness
    Carol A. Burke, MD, FACG
    Identify ways to have work-life balance.
12:45 pm Lunch Break – Visit Exhibit Hall and Browse Scientific Posters
12:45 pm Exhibitor Theater
1:00 pm Poster Session- Authors Present
1:40 pm Exhibitor Theater
2:15 pm   Simultaneous Plenary Sessions 3
  • Simultaneous Plenary Session 3A
  • Simultaneous Plenary Session 3B
3:45 pm Break – Visit Exhibit Hall and Browse Scientific Posters
4:30 pm Emily Couric Memorial Lecture
80% Colorectal Cancer Screening by 2018: How Did We Do and Where Do We Go From Here?
David A. Greenwald, MD, FACG
Introduced by: Irving M. Pike, MD, FACG, ACG President
Describe the goals of the 80% by 2018 campaign for colorectal cancer screening, the successes it has achieved, and plans for the future.
5:00 pm Simultaneous Symposia Session 4

Simultaneous Symposium 4A: Interdisciplinary Management of Variceal Bleeding
Moderator: Guadalupe Garcia-Tsao, MD, FACG

  • Medical Management of Portal Hypertensive Bleeding
    Guadalupe Garcia-Tsao, MD, FACG
    Describe medical management of variceal bleeding as well as its appropriate surveillance.
  • Comprehensive Endoscopic Management of Esophageal and Gastric Varices

    Assess standard as well as state-of-the-art endoscopic and EUS-guided techniques for managing esophageal and gastric variceal bleeding.
  • The Role of Interventional Radiology in the Management of Variceal Bleeding
    Michael C. Soulen, MD
    Interpret radiology techniques as well as appropriate indications to manage esophageal and gastric variceal bleeding.

Simultaneous Symposium 4B: The Colonic Microbiome: C. difficile and Beyond
Moderator: Lawrence J. Brandt, MD, MACG

  • The Colonic Microbiome: What Do We Know in 2018?
    Lawrence J. Brandt, MD, MACG
    Elaborate on the current state of knowledge about the human microbiome; can we test, can we manipulate?
  • Fecal Microbiota Transplant (FMT) in C. difficile infection
    Colleen R. Kelly, MD, FACG
    Explain the biology, technique, and outcomes of FMT in patients with C. difficile infection.
  • Fecal Microbiota Transplant (FMT) for Other Emerging Indications: Potential and Promise
    Paul Moayyedi, MD, MB ChB, PhD, MPH, FACG
    Discuss the emerging data on the efficacy of FMT for other indications beyond C. difficile, including IBD, IBS, obesity, and hepatic encephalopathy.

Simultaneous Symposium 4C: Burning Issues in Barrett’s Esophagus
Moderator: Prasad G. Iyer, MD, FACG

  • Screening and Surveillance – Why and How?
    Prasad G. Iyer, MD, FACG
    Recognize indications for screening and list surveillance recommendations for BE.
  • Predicting Progression to Cancer – The Holy Grail
    Nicholas J. Shaheen, MD, MPH, FACG
    Describe clinical features and biomarkers associated with progression to high grade dysplasia / cancer in Barrett’s esophagus.
  • Tackling Issues in Endoscopic Therapy
    Vani J.A. Konda, MD
    Discuss issues relevant to the management of BE patients without dysplasia, with low grade dysplasia, and after successful ablation.
6:25 pm ACG 2018 Annual Scientific Meeting Adjourns for the day.